June 2026

Safety concerns lead to new recall | FDA approves surgical device | Parents in jail after obese son's death | A fraud warning ()
AI making an impact behind the scenes | New EARLY TAVR data | Americans keep poisoning themselves with semaglutide ()
Week in Review: TAVR vs. SAVR | FDA clears AI tech | Payment model confusion | Private equity & cardiology | Injuries after PCI ()
Heart surgery kits recalled | Sex-specific outcomes after TAVR & SAVR | A new risk calculator | FDA clears tricuspid valve ()
Thousands of heart surgery kits recalled | TAVR for AR linked to 'encouraging' data | Carotid IVL | Progress for new HCM drug ()
AI company founded by cardiologist makes big splash | Getting clinicians on the same page | Kidney injuries after PCI ()
Sweeping TAVR changes on the way | Pushing back against AI-powered prior authorization | FDA highlights recall after injuries ()
Cardiologists added to payment model by mistake | Sex-specific outcomes after TAVR & SAVR | FDA clears new AI software ()
Private equity unlikely to dominate cardiology | Cardiology opposes Medicare AI prior authorization | New AATS leaders ()
The real impact of RVU cuts in electrophysiology | TAVR changes on the way | Cardiology groups celebrate bill | BP drug recalled ()
Blood may leak out of Impella introducers | Leadless conduction and Bachmann's pacing | US study for microvascular disease ()
Top 10 most popular cardiology video interviews this past month ()
Week in Review: CCTA on ACC expo floor gives cardiologist wake-up call | Reaction to CMS TAVR changes | Recalls and new AI ()
CCTA scan provides a wake-up call | Resistance training & heart attack risk in women | New ultrasound tech | AFib & grout ()
FDA clears first surgical valve of its kind | Family files $17M lawsuit | BATMAN to the rescue | Major trends at SCCT 2026 ()
Early reactions to proposed TAVR changes | Cardiology still an AI leader | More than 11K bottles of blood pressure drug recalled ()
TV star's family awarded $13M in malpractice case | Helping patients with ‘broken hearts’ | Cardiac amyloidosis in the spotlight ()
CMS proposes major TAVR changes | The real impact of RVU cuts in electrophysiology | Girl’s heart valve implanted upside down ()
News Alert: CMS proposes major TAVR changes ()
Cath lab kits recalled | Looking ahead to the future of FFR-CT | Medtronic completes major acquisition ()
FDA sees potential in heart failure software | SCCT & SCAI take on CT-derived FFR | Predicting long-term stroke risk ()
Abbott recalls heart monitoring tech | Redo TAVR with balloon-expandable valves | FDA clears new clot-removing device ()
Week in Review: Star Trek star's family awarded $13M | AI for cardiac amyloidosis | TAVR concerns | New CKM syndrome guidelines ()
A brand new payment model | Cardiologist compensation keeps rising | Major medtech player invests $1.5B in TAVR tech ()
Death after TAVR: New data support a change | Rural hospital in spotlight for wrong reason | Heart changes linked to cancer risk ()
Physicians push back after government report | Device recalled | A lesson for PAD patients | AI for long-term stroke risk ()
The pros & cons of direct-to-patient drug programs | Why PAD patients should listen to their doctors ()
Coffee linked to major heart risk | Ablations in ASCs | Catheters recalled | A closer look at PFA | GLP-1 drugs & AFib ()
New guidelines for cardiovascular-kidney-metabolic syndrome and M-TEER | HF cell therapy company raises $4.4 million ()
Cardiac robotic surgery on patient 12,500 miles away | $13M for Star Trek actor HF malpractice case | New leadless pacemaker ()
Supreme Court sides supports cardiac drug maker | X-ray assesses pulmonary valve regurgitation | Making cardiac data actionable ()
Week in Review: Former ACC president dies | Administration questions vascular care | Is coffee bad for the heart | FFR-CT guide ()
New-look pacemaker uses ultrasound to stimulate the heart | Heartflow reports significant revenue growth | CCTA & CTO PCI ()
New FFR-CT standardization consensus document | FDA clears first tricupid surgical valve | ECG AI to detect amyloidosis ()
Shockwave Medical's new IVL catheter | BATMAN to the rescue | Antiplatelet drugs after PCI | FDA announces recalls ()
When TAVR patients require surgery later in life | Colleagues pay tribute to a cardiology powerhouse | Much more ()
TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT ()
Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant ()
Is coffee bad for the heart? | FDA approves new hypertension drug | Stolen devices sold to patients | BP drug recalled ()
OIG questions vascular procedures | Things to consider before signing your next contract | Is coffee bad for the heart? ()
Looking Back: Cardiovascular care hit by major recalls | New payment model on the way | SMART update | Trends in cardiac CT ()
Another Impella warning | Devices stolen, sold to patients | FDA impressed by new AI software | SAPT after TAVR ()